Articles > Health magazines > Medical magazines > Pharma Business Week articles > February 2004

Article: Drug makers sign deal to develop combined diabetes product from Actos, Fortamet.

Article from:
Pharma Business Week
Article date:
February 2, 2004
Copyright

2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Andrx Corporation of Fort Lauderdale, Florida, (ADRX) and Takeda Chemical Industries, Ltd., of Osaka, Japan, have entered into an agreement to develop and market a combination product consisting of Takeda's Actos (Pioglitazone) and Andrx's Fortamet (Metformin extended release), each of which is administered once-a-day for the treatment of type 2 diabetes.

Actos is being marketed in more than 60 countries worldwide while Fortamet was the subject of an October 2003 approvable letter from the United States Food and Drug Administration.

Once approved, this combination product will be manufactured by Andrx, and ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: First Horizon Announces Completion of Acquisition of Worldwide ...
Business Wire;  March 29, 2005 ;     700+ words ... ... prescription medication Fortamet(R) (metformin ... lovastatin) from Andrx Corporation ("Andrx ... supply agreement with Andrx. Fortamet(R) is a patented ... transaction with Andrx. We are excited ... growth potential of Fortamet(R) and Altoprev ...

Article: Andrx and Takeda Collaborate on Combination Product of ...
Business Wire;  January 7, 2004 ;     700+ words ... ... R) (Pioglitazone) and Andrx's Fortamet(R) (Metformin Extended ... adequate blood sugar control. Fortamet, Andrx's second internally developed ... in the first half of 2004. Andrx anticipates that Fortamet will be specifically indicated ...

Article: First Horizon Announces Agreement to Acquire Worldwide Rights to ...
Business Wire;  March 2, 2005 ;     700+ words ... ... diabetes prescription medication Fortamet(TM) (metformin hydrochloride ... Altoprev(R) (lovastatin) from Andrx Corporation ("Andrx"). The Company has also entered ... manufacturing and supply agreement with Andrx. Fortamet is a patented, once-a-day ...

Article: Andrx Receives FDA Approval of Fortamet; Also Plans ...
Business Wire;  April 28, 2004 ;     700+ words ... ... patients with type 2 diabetes. Andrx is planning to launch Fortamet in May 2004. Thomas P ... demonstrate the value of Andrx's controlled-release technologies." Fortamet extended-release tablets employ Andrx's patented single-composition ...

Article: The FDA has approved Andrx's Fortamet (metformin ...
Medical Marketing & Media;  June 1, 2004 ;     612 words ...The FDA has approved Andrx's Fortamet (metformin HCI) extended-release tablets, 500 mg and 1000 mg, for use as an adjunct to diet and exercise to lower blood glucose in patients with type 2 diabetes. Andrx planned to launch Fortamet in May.

Article: Andrx Completes Divestiture of Fortamet and ...
Business Wire;  March 29, 2005 ;     700+ words ... ... Corporation ("First Horizon"). Andrx received $50 million for Fortamet at the closing. Andrx is entitled to receive up to ... sales, as defined, of 8% on Fortamet and 15% on Altoprev. Thomas P. Rice, Andrx's Chief Executive Officer ...

Article: Andrx to Divest Altoprev and Fortamet to First ...
Business Wire;  March 2, 2005 ;     700+ words ...FORT LAUDERDALE, Fla. -- Andrx Corporation (Nasdaq:ADRX) ("Andrx") today announced that it ... licensing of certain rights to its Fortamet(R) and Altoprev(R) brand ... First Horizon has agreed to pay Andrx $50 million at closing and ...

Article: Andrx.(approval for Fortamet)(Brief Article)
Drug Store News;  November 17, 2003 ;     532 words ...Andrx received an approvable letter from the FDA for its Fortamet (metformin extended-release) tablets, 500 mg and 1,000 rag. Fortamet is Andrx's second internally developed brand product ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives